Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina have?
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina published?
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina has 2025 year in the ScholarIQ index.
What is the open-access status of Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina?
Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina has diamond oa status in the ScholarIQ index.
What is the DOI of Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina?
The DOI for Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina is on the source record.
What is the PMID of Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina?
The PMID for Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina is on the source record.
What is the OpenAlex record for Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina?
The OpenAlex for Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina is on the source record.